The telomeric protein Pot1 from Schizosaccharomyces pombe binds ssDNA in two modes with differing 3′ end availability

por Dickey, Thayne H., Wuttke, Deborah S.
Publicado 2014

The SMAD3 transcription factor binds complex RNA structures with high affinity

por Dickey, Thayne H., Pyle, Anna M.
Publicado 2017

RNA binding activates RIG-I by releasing an autorepressed signaling domain

por Dickey, T. H., Song, B., Pyle, A. M.
Publicado 2019

A minimal RNA ligand for potent RIG-I activation in living mice

por Linehan, Melissa M., Dickey, Thayne H., Molinari, Emanuela S., Fitzgerald, Megan E., Potapova, Olga, Iwasaki, Akiko, Pyle, Anna M.
Publicado 2018

Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response

por Dickey, Thayne H., Tang, Wai Kwan, Butler, Brandi, Ouahes, Tarik, Orr-Gonzalez, Sachy, Salinas, Nichole D., Lambert, Lynn E., Tolia, Niraj H.
Publicado 2022

A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle

por Salinas, Nichole D., Ma, Rui, Dickey, Thayne H., McAleese, Holly, Ouahes, Tarik, Long, Carole A., Miura, Kazutoyo, Lambert, Lynn E., Tolia, Niraj H.
Publicado 2023

Neutralizing and interfering human antibodies define the structural and mechanistic basis for antigenic diversion

por Patel, Palak N., Dickey, Thayne H., Hopp, Christine S., Diouf, Ababacar, Tang, Wai Kwan, Long, Carole A., Miura, Kazutoyo, Crompton, Peter D., Tolia, Niraj H.
Publicado 2022

Structure-based design of a strain transcending AMA1-RON2L malaria vaccine

por Patel, Palak N., Dickey, Thayne H., Diouf, Ababacar, Salinas, Nichole D., McAleese, Holly, Ouahes, Tarik, Long, Carole A., Miura, Kazutoyo, Lambert, Lynn E., Tolia, Niraj H.
Publicado 2023

Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines

por Scaria, Puthupparampil V., Rowe, Chris G., Chen, Beth B., Dickey, Thayne H., Renn, Jonathan P., Lambert, Lynn E., Barnafo, Emma K., Rausch, Kelly M., Tolia, Niraj H., Duffy, Patrick E.
Publicado 2022

Design of a stabilized non-glycosylated Pfs48/45 antigen enables a potent malaria transmission-blocking nanoparticle vaccine

por Dickey, Thayne H., Gupta, Richi, McAleese, Holly, Ouahes, Tarik, Orr-Gonzalez, Sachy, Ma, Rui, Muratova, Olga, Salinas, Nichole D., Hume, Jen C. C., Lambert, Lynn E., Duffy, Patrick E., Tolia, Niraj H.
Publicado 2023

Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines

por Dickey, Thayne H., Ma, Rui, Orr-Gonzalez, Sachy, Ouahes, Tarik, Patel, Palak, McAleese, Holly, Butler, Brandi, Eudy, Elizabeth, Eaton, Brett, Murphy, Michael, Kwan, Jennifer L., Salinas, Nichole D., Holbrook, Michael R., Lambert, Lynn E., Tolia, Niraj H.
Publicado 2023